PP_1170x120_10-25-21

National Institutes of Health (NIH)

NIH launches clinical trails network to test COVID-19 vaccines, other tools

NIH launches clinical trails network to test COVID-19 vaccines, other tools

WASHINGTON — The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19. The COVID-19 Prevention Trials

NIH helps fund ColCorona COVID-19 clinical study

NIH helps fund ColCorona COVID-19 clinical study

MONTREAL — The Montreal Heart Institute (MHI) Research Center today announced that, through its association with NYU Langone, its clinical study on COVID-19 has received funding from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health (NIH), one of the world’s foremost medical research centers. ColCorona is one of the

NIH clinical trial shows remdesivir speeds up recovery from advanced COVID-19

NIH clinical trial shows remdesivir speeds up recovery from advanced COVID-19

BETHESDA, Md.— Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute

Genoa Healthcare participating in opioid treatment study

Genoa Healthcare participating in opioid treatment study

EAGAN, Minn. — A  new National Institutes of Health (NIH)-funded study is underway that’s examining the effectiveness of putting pharmacists in the role of caring of people with substance use disorder. It’s being led by Rhode Island Hospital, with Genoa Healthcare pharmacies providing medication and care to patients. Rhode Island Hospital has been awarded $1.6

USF clinical trial seeks to reduce risk of Alzheimer’s, delay effects from disease

USF clinical trial seeks to reduce risk of Alzheimer’s, delay effects from disease

ST. PETERSBURG, Fla. — What if solving brain games and puzzles on a computer could reduce the chances of developing dementia such as Alzheimer’s or delay the debilitating loss of function associated with the disease? That’s the question researchers from the University of South Florida (USF) are seeking to answer through a pioneering new study that